Amprius Technologies, Inc. — Form 8-K Summary
Business Context and Reporting Period
Amprius Technologies, Inc. develops silicon nanowire anodes and related lithium-ion battery technology. This Current Report on Form 8-K reports events occurring on October 19 and October 20, 2022, and does not provide quarterly or annual financial results.
Key Financial and Operating Information
- The Company announced a potential $50 million cost-sharing grant from the U.S. Department of Energy.
- The grant remains dependent on successful negotiation of a final contract. The portion of eligible costs covered by the grant had not been finalized.
- The Company received its first large-scale anode production machine from centrotherm. It plans to install the machine at its Fremont, California facility.
- The equipment is intended to support preparation for construction of a high-volume manufacturing facility and production of the Company’s silicon nanowire anode.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other periodic financial metrics.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial information. The material developments are the potential DOE grant award and receipt of the first large-scale anode production machine.
Guidance, Outlook, Risks, and Unusual Items
- Management’s forward-looking statements include expectations regarding the DOE grant, development of a high-volume manufacturing facility, performance of the centrotherm equipment, and the ability to produce products commercially.
- The grant amount and coverage terms remain subject to final contract negotiations and should not be treated as committed funding until the contract is finalized.
- Key risks include delays in facility construction or operations, equipment performance, the timing of business milestones, supply shortages, competition, changes to government clean-energy and electric-vehicle incentives, liquidity constraints, and broader market, political, legal, and financial conditions.
- The Company cautions that actual results may differ materially from its forward-looking statements and disclaims an obligation to update them except as required by law.
Facts Investors Should Verify
- Whether the DOE cost-sharing grant contract was ultimately executed and the final eligible-cost coverage percentage.
- The timing, funding requirements, and construction status of the planned high-volume manufacturing facility.
- Installation, qualification, and production performance of the centrotherm machine.
- The Company’s liquidity, cash-burn rate, capital requirements, and ability to fund commercialization, which are not provided in this filing.
- Whether the Company achieved commercial-scale production and related customer or revenue milestones.